Erratum: The cytokine interleukin-33 mediates anaphylactic shock (Proceedings of the National Academy of Sciences United States of America (2009) 106, (9773-9778) DOI: 10.1073/pnas.0901206106));The cytokine interleukin-33 mediates anaphylactic shock

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 24, 2009, Pages 9773-9778

  Pushparaj, Peter N ^a   Hwee, Kee Tay ^a   Shiau, Chen H'ng ^b   Pitman, Nick ^a   Xu, Damo ^a   McKenzie, Andrew ^c   Liew, Foo Y ^a   Melendez, Alirio J ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Anaphylaxis; Cytokine biology; IL 33

Indexed keywords

ICOSANOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 33; ORPHAN RECEPTOR ST2; PHOSPHOLIPASE D1; RECEPTOR; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG;

ADULT; ANAPHYLACTIC SHOCK; ARTICLE; ATOPIC DERMATITIS; CALCIUM MOBILIZATION; CONTROLLED STUDY; DEGRANULATION; FEMALE; HUMAN; HUMAN CELL; MALE; MAST CELL; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE;

MURINAE; MUS;

EID: 67649852593     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1210844109     Document Type: Erratum

References (35)

1. Schmitz J, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479-490. (Pubitemid 41587888)
2. O'Neill LA, Dinarello CA (2000) The IL-1 receptor/Toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol Today 21:206-209. (Pubitemid 30259023)
3. Moritz DR, Rodewald HR, Gheyselinck J, Klemenz R (1998) The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J Immunol 161:4866-4874. (Pubitemid 28492065)
4. Xu D, Chan WL, Leung BP, Huang F, Wheeler R (1998) Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187:787-794. (Pubitemid 28115194)
5. Brint EK, et al. (2004) ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 5:373-379. (Pubitemid 38500085)
6. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN (2000) T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 191:1069-1076. (Pubitemid 30691409)
7. Oshikawa K, et al. (2001) Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 164:277-281. (Pubitemid 34001295)
8. Shimpo M, et al. (2004) Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109:2186-2190. (Pubitemid 38625395)
9. Sanada S, et al. (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117:1538-1549. (Pubitemid 46871338)
10. Verri WA, Jr, et al. (2008) IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci USA 105:2723-2728.
11. Miller AM, et al. (2008) IL-33 reduces the development of atherosclerosis. J Exp Med 205:339-346.
12. Wedemeyer J, Tsai M, Galli SJ (2000) Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 12:624-631. (Pubitemid 30847885)
13. Galli SJ, et al. (2005) Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23:749-786.
14. Moulin D, et al. (2007) Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40:216-225. (Pubitemid 350213434)
15. Ho LH, et al. (2007) IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukoc Biol 82:1481-1490. (Pubitemid 350276960)
16. Iikura M, et al. (2007) IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 87:971-978. (Pubitemid 47429189)
17. Allakhverdi Z, Smith DE, Comeau MR, Delespesse G (2007) Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179:2051-2054.
18. Ando A, Martin TR, Galli SJ (1993) Effects of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. Genetically mast cell-deficient Sl/Sld mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses. J Clin Invest 92:1639-1649. (Pubitemid 23304525)
19. Martin TR, Galli SJ, Katona IM, Drazen JM (1989) Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J Clin Invest 83:1375-1383. (Pubitemid 19113055)
20. Ujike A, et al. (1999) Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J Exp Med 189:1573-1579. (Pubitemid 29240882)
21. Mombaerts P, et al. (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877.
22. Melendez AJ, Harnett MM, Allen JM (1999) FcgammaRI activation of phospholipase Cgamma1 and protein kinase C in dibutyryl cAMP-differentiated U937 cells is dependent solely on the tyrosine-kinase activated form of phosphatidylinositol-3-kinase. Immunology 98:1-8. (Pubitemid 29425902)
23. Melendez A, et al. (1998) A molecular switch changes the signalling pathway used by the Fc gamma RI antibody receptor to mobilise calcium. Curr Biol 8:210-221. (Pubitemid 28126611)
24. Melendez AJ, Bruetschy L, Floto RA, Harnett MM, Allen JM (2001) Functional coupling of FcγRI to nicotinamide adenine dinucleotide phosphate (reduced form) oxidative burst and immune complex trafficking requires the activation of phospholipase D1. Blood 98:3421-3428.
25. Melendez AJ, Khaw AK (2002) Dichotomy of Ca2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J Biol Chem 277:17255-17262. (Pubitemid 34967760)
26. Melendez AJ, et al. (2007) Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat Med 13:1375-1381. (Pubitemid 350073593)
27. Marquardt DL, Walker LL (2000) Dependence of mast cell IgE-mediated cytokine production on nuclear factor-kappaB activity. J Allergy Clin Immunol 105:500-505. (Pubitemid 30169908)
28. Stassen M, et al. (2001) IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol 166:4391-4398. (Pubitemid 32233721)
29. Coward WR, et al. (2002) NF-kappa B and TNF-alpha: A positive autocrine loop in human lung mast cells? J Immunol 169:5287-5293.
30. Masuda A, Yoshikai Y, Aiba K, Matsuguchi T (2002) J Immunol 169:3801-3810.
31. Dolmetsch RE, Xu K, Lewis RS (1998) Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392:933-936. (Pubitemid 28232066)
32. Blank U, Rivera J (2004) The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 25:266-273. (Pubitemid 38501673)
33. Kinet JP (1999) The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 17:931-972. (Pubitemid 29241144)
34. Jayapal M, et al. (2006) Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genomics 7:210-215. (Pubitemid 44390020)
35. Malbec O, et al. (2007) Peritoneal cell-derived mast cells: An in vitro model of mature serosal-type mouse mast cells. J Immunol 178:6465-6475. (Pubitemid 46717430)